Department of Clinical Physiology and Nuclear Medicine, Center for Functional and Diagnostic Imaging and Research, University of Copenhagen, Copenhagen, Denmark.
Gastro Unit, Medical Division, Faculty of Health Sciences, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark.
Liver Int. 2018 Apr;38(4):570-580. doi: 10.1111/liv.13589. Epub 2018 Jan 15.
Patients with cirrhosis and portal hypertension often develop complications from a variety of organ systems leading to a multiple organ failure. The combination of liver failure and portal hypertension results in a hyperdynamic circulatory state partly owing to simultaneous splanchnic and peripheral arterial vasodilatation. Increases in circulatory vasodilators are believed to be due to portosystemic shunting and bacterial translocation leading to redistribution of the blood volume with central hypovolemia. Portal hypertension per se and increased splanchnic blood flow are mainly responsible for the development and perpetuation of the hyperdynamic circulation and the associated changes in cardiovascular function with development of cirrhotic cardiomyopathy, autonomic dysfunction and renal dysfunction as part of a cardiorenal syndrome. Several of the cardiovascular changes are reversible after liver transplantation and point to the pathophysiological significance of portal hypertension. In this paper, we aimed to review current knowledge on the pathophysiology of arterial vasodilatation and the hyperdynamic circulation in cirrhosis.
肝硬化和门静脉高压症患者常因多种器官系统的并发症导致多器官衰竭。肝功能衰竭和门静脉高压症的结合导致高动力循环状态,部分原因是同时发生的内脏和外周动脉血管扩张。循环血管扩张剂的增加被认为是由于门体分流和细菌易位导致血容量重新分布,中心低血容量。门静脉高压症本身和内脏血流量增加主要负责高动力循环的发展和持续,并伴有肝硬化心肌病、自主神经功能障碍和肾功能障碍等心血管功能相关变化,这是心肾综合征的一部分。一些心血管变化在肝移植后是可逆的,这表明门静脉高压症的病理生理学意义。本文旨在综述肝硬化时动脉血管扩张和高动力循环的病理生理学知识。